nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—GNRHR—hindbrain—epilepsy syndrome	0.0236	0.334	CbGeAlD
Nafarelin—GNRHR—brainstem—epilepsy syndrome	0.0135	0.192	CbGeAlD
Nafarelin—Vapreotide—SSTR5—epilepsy syndrome	0.00789	0.493	CrCbGaD
Nafarelin—GNRHR—head—epilepsy syndrome	0.00747	0.106	CbGeAlD
Nafarelin—GNRHR—nervous system—epilepsy syndrome	0.00708	0.1	CbGeAlD
Nafarelin—GNRHR—central nervous system—epilepsy syndrome	0.00682	0.0967	CbGeAlD
Nafarelin—GNRHR—cerebellum—epilepsy syndrome	0.00666	0.0945	CbGeAlD
Nafarelin—Vapreotide—SSTR2—epilepsy syndrome	0.00598	0.373	CrCbGaD
Nafarelin—GNRHR—brain—epilepsy syndrome	0.00541	0.0767	CbGeAlD
Nafarelin—Pentagastrin—BCHE—epilepsy syndrome	0.00174	0.109	CrCbGaD
Nafarelin—GNRHR—G alpha (q) signalling events—AVP—epilepsy syndrome	0.000854	0.0033	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GAL—epilepsy syndrome	0.000829	0.0032	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL2—epilepsy syndrome	0.000825	0.00319	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—OXT—epilepsy syndrome	0.000825	0.00319	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—epilepsy syndrome	0.000825	0.00319	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GRM5—epilepsy syndrome	0.00082	0.00316	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CHRM3—epilepsy syndrome	0.00082	0.00316	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ACKR4—epilepsy syndrome	0.00081	0.00313	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.000807	0.00311	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.000807	0.00311	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.000786	0.00303	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR10—epilepsy syndrome	0.000773	0.00299	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.000771	0.00298	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CHRM2—epilepsy syndrome	0.000771	0.00298	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.000771	0.00298	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	0.000764	0.00295	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GABBR1—epilepsy syndrome	0.00075	0.00289	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.000746	0.00288	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.000746	0.00288	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—SSTR5—epilepsy syndrome	0.000733	0.00283	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—SSTR4—epilepsy syndrome	0.000733	0.00283	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.00073	0.00282	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HRH3—epilepsy syndrome	0.000719	0.00278	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—HTR2A—epilepsy syndrome	0.000711	0.00274	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—OPRM1—epilepsy syndrome	0.000708	0.00273	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR10—epilepsy syndrome	0.000702	0.00271	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.000702	0.00271	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.000702	0.00271	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.000689	0.00266	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GRM2—epilepsy syndrome	0.000676	0.00261	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—AGT—epilepsy syndrome	0.000674	0.0026	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.000672	0.00259	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR3—epilepsy syndrome	0.000668	0.00258	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—NPY—epilepsy syndrome	0.000651	0.00251	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	0.000636	0.00245	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—OXT—epilepsy syndrome	0.000628	0.00243	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CRH—epilepsy syndrome	0.000628	0.00243	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000628	0.00243	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL3—epilepsy syndrome	0.000628	0.00243	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GRM2—epilepsy syndrome	0.000614	0.00237	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.000611	0.00236	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	0.000603	0.00233	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.000586	0.00226	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.000586	0.00226	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR9—epilepsy syndrome	0.000586	0.00226	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.000586	0.00226	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR8—epilepsy syndrome	0.000586	0.00226	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GRM4—epilepsy syndrome	0.000575	0.00222	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GRM3—epilepsy syndrome	0.000575	0.00222	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR2—epilepsy syndrome	0.000568	0.00219	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—SST—epilepsy syndrome	0.000568	0.00219	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000566	0.00218	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000564	0.00218	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000556	0.00215	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000555	0.00214	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	0.000555	0.00214	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000547	0.00211	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRDM4—epilepsy syndrome	0.000547	0.00211	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000545	0.0021	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000534	0.00206	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000534	0.00206	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000532	0.00205	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000532	0.00205	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000532	0.00205	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR8—epilepsy syndrome	0.000532	0.00205	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR9—epilepsy syndrome	0.000532	0.00205	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CNR1—epilepsy syndrome	0.000524	0.00202	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GRM4—epilepsy syndrome	0.000522	0.00201	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GRM3—epilepsy syndrome	0.000522	0.00201	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.00052	0.00201	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000512	0.00198	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HTR7—epilepsy syndrome	0.000512	0.00198	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000498	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000498	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000498	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000498	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GRM8—epilepsy syndrome	0.000495	0.00191	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000481	0.00186	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ACKR4—epilepsy syndrome	0.000479	0.00185	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000472	0.00182	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000472	0.00182	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000471	0.00182	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GAL—epilepsy syndrome	0.000469	0.00181	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000463	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000463	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000453	0.00175	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GRM1—epilepsy syndrome	0.000453	0.00175	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PDYN—epilepsy syndrome	0.000453	0.00175	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR7—epilepsy syndrome	0.000453	0.00175	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000447	0.00172	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000436	0.00168	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000436	0.00168	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SSTR5—epilepsy syndrome	0.000433	0.00167	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SSTR4—epilepsy syndrome	0.000433	0.00167	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—AVP—epilepsy syndrome	0.000431	0.00166	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GAL—epilepsy syndrome	0.000426	0.00164	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000424	0.00164	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GRM5—epilepsy syndrome	0.000421	0.00162	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000421	0.00162	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR10—epilepsy syndrome	0.000415	0.0016	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000406	0.00157	CbGpPWpGaD
Nafarelin—Desmopressin—PTGS2—epilepsy syndrome	0.000406	0.0254	CrCbGaD
Nafarelin—GNRHR—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000403	0.00156	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.0004	0.00154	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000396	0.00153	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000396	0.00153	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000396	0.00153	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000385	0.00149	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000378	0.00146	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000376	0.00145	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HRH3—epilepsy syndrome	0.000369	0.00142	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPY—epilepsy syndrome	0.000368	0.00142	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000368	0.00142	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR5—epilepsy syndrome	0.000366	0.00141	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000363	0.0014	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GRM2—epilepsy syndrome	0.000363	0.0014	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000358	0.00138	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—OXT—epilepsy syndrome	0.000355	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CRH—epilepsy syndrome	0.000355	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000355	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR3—epilepsy syndrome	0.000343	0.00132	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—AGT—epilepsy syndrome	0.00034	0.00131	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPY—epilepsy syndrome	0.000334	0.00129	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SSTR3—epilepsy syndrome	0.000328	0.00127	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL3—epilepsy syndrome	0.000322	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—OXT—epilepsy syndrome	0.000322	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000322	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CRH—epilepsy syndrome	0.000322	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—SST—epilepsy syndrome	0.000321	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000321	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000321	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000314	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPY2R—epilepsy syndrome	0.000314	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR9—epilepsy syndrome	0.000314	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SSTR1—epilepsy syndrome	0.000314	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR8—epilepsy syndrome	0.000314	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000314	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GRM3—epilepsy syndrome	0.000308	0.00119	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GRM4—epilepsy syndrome	0.000308	0.00119	CbGpPWpGaD
Nafarelin—Headache—Acetazolamide—epilepsy syndrome	0.000304	0.000464	CcSEcCtD
Nafarelin—Urticaria—Zonisamide—epilepsy syndrome	0.000303	0.000464	CcSEcCtD
Nafarelin—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000303	0.000464	CcSEcCtD
Nafarelin—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000303	0.000463	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—DUSP4—epilepsy syndrome	0.000303	0.00117	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SSTR2—epilepsy syndrome	0.000303	0.00117	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000302	0.00117	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000302	0.00117	CbGpPWpGaD
Nafarelin—Asthenia—Fosphenytoin—epilepsy syndrome	0.000301	0.000461	CcSEcCtD
Nafarelin—Alopecia—Pregabalin—epilepsy syndrome	0.000301	0.000461	CcSEcCtD
Nafarelin—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000301	0.000459	CcSEcCtD
Nafarelin—Weight increased—Topiramate—epilepsy syndrome	0.000299	0.000457	CcSEcCtD
Nafarelin—Mental disorder—Pregabalin—epilepsy syndrome	0.000299	0.000457	CcSEcCtD
Nafarelin—Constipation—Carbamazepine—epilepsy syndrome	0.000298	0.000456	CcSEcCtD
Nafarelin—Dizziness—Propofol—epilepsy syndrome	0.000298	0.000455	CcSEcCtD
Nafarelin—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000298	0.000455	CcSEcCtD
Nafarelin—Weight decreased—Topiramate—epilepsy syndrome	0.000297	0.000454	CcSEcCtD
Nafarelin—Pruritus—Fosphenytoin—epilepsy syndrome	0.000297	0.000454	CcSEcCtD
Nafarelin—Malnutrition—Pregabalin—epilepsy syndrome	0.000297	0.000454	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000296	0.00114	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000295	0.00114	CbGpPWpGaD
Nafarelin—Vertigo—Valproic Acid—epilepsy syndrome	0.000295	0.000451	CcSEcCtD
Nafarelin—Asthenia—Vigabatrin—epilepsy syndrome	0.000294	0.000449	CcSEcCtD
Nafarelin—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000293	0.000448	CcSEcCtD
Nafarelin—Urticaria—Clonazepam—epilepsy syndrome	0.000292	0.000447	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—GRM8—epilepsy syndrome	0.000292	0.00113	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PGF—epilepsy syndrome	0.000292	0.00113	CbGpPWpGaD
Nafarelin—Depression—Topiramate—epilepsy syndrome	0.000292	0.000447	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCR2—epilepsy syndrome	0.000292	0.00113	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—SST—epilepsy syndrome	0.000292	0.00113	CbGpPWpGaD
Nafarelin—Dizziness—Midazolam—epilepsy syndrome	0.000291	0.000445	CcSEcCtD
Nafarelin—Tension—Pregabalin—epilepsy syndrome	0.000291	0.000445	CcSEcCtD
Nafarelin—Dysgeusia—Pregabalin—epilepsy syndrome	0.000291	0.000444	CcSEcCtD
Nafarelin—Urticaria—Phenytoin—epilepsy syndrome	0.00029	0.000444	CcSEcCtD
Nafarelin—Palpitations—Valproic Acid—epilepsy syndrome	0.00029	0.000443	CcSEcCtD
Nafarelin—Pruritus—Vigabatrin—epilepsy syndrome	0.00029	0.000443	CcSEcCtD
Nafarelin—Asthenia—Diazepam—epilepsy syndrome	0.000289	0.000442	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000289	0.00112	CbGpPWpGaD
Nafarelin—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000289	0.000441	CcSEcCtD
Nafarelin—Constipation—Lamotrigine—epilepsy syndrome	0.000288	0.000441	CcSEcCtD
Nafarelin—Nervousness—Pregabalin—epilepsy syndrome	0.000288	0.000441	CcSEcCtD
Nafarelin—Nausea—Acetazolamide—epilepsy syndrome	0.000288	0.00044	CcSEcCtD
Nafarelin—Dizziness—Levetiracetam—epilepsy syndrome	0.000288	0.00044	CcSEcCtD
Nafarelin—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000287	0.000439	CcSEcCtD
Nafarelin—Vomiting—Propofol—epilepsy syndrome	0.000286	0.000438	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—POMC—epilepsy syndrome	0.000286	0.0011	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000285	0.0011	CbGpPWpGaD
Nafarelin—Pruritus—Diazepam—epilepsy syndrome	0.000285	0.000436	CcSEcCtD
Nafarelin—Conjunctivitis—Topiramate—epilepsy syndrome	0.000285	0.000435	CcSEcCtD
Nafarelin—Rash—Propofol—epilepsy syndrome	0.000284	0.000434	CcSEcCtD
Nafarelin—Dermatitis—Propofol—epilepsy syndrome	0.000284	0.000434	CcSEcCtD
Nafarelin—Headache—Propofol—epilepsy syndrome	0.000282	0.000431	CcSEcCtD
Nafarelin—Vomiting—Midazolam—epilepsy syndrome	0.00028	0.000428	CcSEcCtD
Nafarelin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00028	0.000428	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCL2—epilepsy syndrome	0.00028	0.00108	CbGpPWpGaD
Nafarelin—Asthenia—Felbamate—epilepsy syndrome	0.00028	0.000428	CcSEcCtD
Nafarelin—Myalgia—Valproic Acid—epilepsy syndrome	0.00028	0.000427	CcSEcCtD
Nafarelin—Chest pain—Valproic Acid—epilepsy syndrome	0.00028	0.000427	CcSEcCtD
Nafarelin—Arthralgia—Valproic Acid—epilepsy syndrome	0.00028	0.000427	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—OPRD1—epilepsy syndrome	0.000279	0.00108	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GNAO1—epilepsy syndrome	0.000279	0.00108	CbGpPWpGaD
Nafarelin—Rash—Midazolam—epilepsy syndrome	0.000278	0.000425	CcSEcCtD
Nafarelin—Dizziness—Fosphenytoin—epilepsy syndrome	0.000278	0.000424	CcSEcCtD
Nafarelin—Dermatitis—Midazolam—epilepsy syndrome	0.000278	0.000424	CcSEcCtD
Nafarelin—Urticaria—Carbamazepine—epilepsy syndrome	0.000277	0.000424	CcSEcCtD
Nafarelin—Vomiting—Levetiracetam—epilepsy syndrome	0.000277	0.000423	CcSEcCtD
Nafarelin—Epistaxis—Topiramate—epilepsy syndrome	0.000276	0.000422	CcSEcCtD
Nafarelin—Alopecia—Gabapentin—epilepsy syndrome	0.000276	0.000422	CcSEcCtD
Nafarelin—Headache—Midazolam—epilepsy syndrome	0.000276	0.000422	CcSEcCtD
Nafarelin—Pruritus—Felbamate—epilepsy syndrome	0.000276	0.000422	CcSEcCtD
Nafarelin—Diarrhoea—Diazepam—epilepsy syndrome	0.000276	0.000421	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000276	0.00106	CbGpPWpGaD
Nafarelin—Sinusitis—Topiramate—epilepsy syndrome	0.000275	0.00042	CcSEcCtD
Nafarelin—Rash—Levetiracetam—epilepsy syndrome	0.000274	0.000419	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000274	0.00106	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000274	0.00106	CbGpPWpGaD
Nafarelin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000274	0.000419	CcSEcCtD
Nafarelin—Asthenia—Zonisamide—epilepsy syndrome	0.000274	0.000419	CcSEcCtD
Nafarelin—Mental disorder—Gabapentin—epilepsy syndrome	0.000274	0.000419	CcSEcCtD
Nafarelin—Headache—Levetiracetam—epilepsy syndrome	0.000273	0.000417	CcSEcCtD
Nafarelin—Malnutrition—Gabapentin—epilepsy syndrome	0.000272	0.000416	CcSEcCtD
Nafarelin—Dizziness—Vigabatrin—epilepsy syndrome	0.000271	0.000414	CcSEcCtD
Nafarelin—Pruritus—Zonisamide—epilepsy syndrome	0.00027	0.000413	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CNR1—epilepsy syndrome	0.000269	0.00104	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000268	0.00104	CbGpPWpGaD
Nafarelin—Oedema—Valproic Acid—epilepsy syndrome	0.000268	0.00041	CcSEcCtD
Nafarelin—Urticaria—Lamotrigine—epilepsy syndrome	0.000268	0.000409	CcSEcCtD
Nafarelin—Nausea—Propofol—epilepsy syndrome	0.000268	0.000409	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CHRM1—epilepsy syndrome	0.000267	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PDYN—epilepsy syndrome	0.000267	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR7—epilepsy syndrome	0.000267	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GRM1—epilepsy syndrome	0.000267	0.00103	CbGpPWpGaD
Nafarelin—Tension—Gabapentin—epilepsy syndrome	0.000267	0.000408	CcSEcCtD
Nafarelin—Vomiting—Fosphenytoin—epilepsy syndrome	0.000267	0.000408	CcSEcCtD
Nafarelin—Diarrhoea—Felbamate—epilepsy syndrome	0.000267	0.000408	CcSEcCtD
Nafarelin—Vertigo—Pregabalin—epilepsy syndrome	0.000267	0.000408	CcSEcCtD
Nafarelin—Dysgeusia—Gabapentin—epilepsy syndrome	0.000267	0.000407	CcSEcCtD
Nafarelin—Dizziness—Diazepam—epilepsy syndrome	0.000267	0.000407	CcSEcCtD
Nafarelin—Rash—Fosphenytoin—epilepsy syndrome	0.000265	0.000405	CcSEcCtD
Nafarelin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000265	0.000404	CcSEcCtD
Nafarelin—Nervousness—Gabapentin—epilepsy syndrome	0.000264	0.000404	CcSEcCtD
Nafarelin—Asthenia—Clonazepam—epilepsy syndrome	0.000264	0.000404	CcSEcCtD
Nafarelin—Rhinitis—Topiramate—epilepsy syndrome	0.000264	0.000403	CcSEcCtD
Nafarelin—Headache—Fosphenytoin—epilepsy syndrome	0.000263	0.000402	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—HTR7—epilepsy syndrome	0.000263	0.00101	CbGpPWpGaD
Nafarelin—Palpitations—Pregabalin—epilepsy syndrome	0.000262	0.000401	CcSEcCtD
Nafarelin—Asthenia—Phenytoin—epilepsy syndrome	0.000262	0.000401	CcSEcCtD
Nafarelin—Nausea—Midazolam—epilepsy syndrome	0.000262	0.0004	CcSEcCtD
Nafarelin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000261	0.000399	CcSEcCtD
Nafarelin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000261	0.000399	CcSEcCtD
Nafarelin—Pruritus—Clonazepam—epilepsy syndrome	0.00026	0.000398	CcSEcCtD
Nafarelin—Vomiting—Vigabatrin—epilepsy syndrome	0.00026	0.000398	CcSEcCtD
Nafarelin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000259	0.000396	CcSEcCtD
Nafarelin—Pruritus—Phenytoin—epilepsy syndrome	0.000259	0.000395	CcSEcCtD
Nafarelin—Nausea—Levetiracetam—epilepsy syndrome	0.000259	0.000395	CcSEcCtD
Nafarelin—Rash—Vigabatrin—epilepsy syndrome	0.000258	0.000395	CcSEcCtD
Nafarelin—Dizziness—Felbamate—epilepsy syndrome	0.000258	0.000394	CcSEcCtD
Nafarelin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000258	0.000394	CcSEcCtD
Nafarelin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000257	0.000393	CcSEcCtD
Nafarelin—Convulsion—Pregabalin—epilepsy syndrome	0.000257	0.000393	CcSEcCtD
Nafarelin—Headache—Vigabatrin—epilepsy syndrome	0.000257	0.000392	CcSEcCtD
Nafarelin—Vomiting—Diazepam—epilepsy syndrome	0.000256	0.000392	CcSEcCtD
Nafarelin—Anorexia—Valproic Acid—epilepsy syndrome	0.000255	0.00039	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000255	0.000984	CbGpPWpGaD
Nafarelin—Rash—Diazepam—epilepsy syndrome	0.000254	0.000388	CcSEcCtD
Nafarelin—Dermatitis—Diazepam—epilepsy syndrome	0.000254	0.000388	CcSEcCtD
Nafarelin—Arthralgia—Pregabalin—epilepsy syndrome	0.000253	0.000386	CcSEcCtD
Nafarelin—Myalgia—Pregabalin—epilepsy syndrome	0.000253	0.000386	CcSEcCtD
Nafarelin—Chest pain—Pregabalin—epilepsy syndrome	0.000253	0.000386	CcSEcCtD
Nafarelin—Dizziness—Zonisamide—epilepsy syndrome	0.000253	0.000386	CcSEcCtD
Nafarelin—Headache—Diazepam—epilepsy syndrome	0.000253	0.000386	CcSEcCtD
Nafarelin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000252	0.000385	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000251	0.00097	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GFAP—epilepsy syndrome	0.000251	0.00097	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GAL—epilepsy syndrome	0.000251	0.00097	CbGpPWpGaD
Nafarelin—Asthenia—Carbamazepine—epilepsy syndrome	0.00025	0.000383	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—AKT3—epilepsy syndrome	0.00025	0.000966	CbGpPWpGaD
Nafarelin—Diarrhoea—Phenytoin—epilepsy syndrome	0.00025	0.000382	CcSEcCtD
Nafarelin—Nausea—Fosphenytoin—epilepsy syndrome	0.00025	0.000381	CcSEcCtD
Nafarelin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000249	0.00038	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CASP2—epilepsy syndrome	0.000249	0.000959	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CHRM3—epilepsy syndrome	0.000249	0.000959	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GRM5—epilepsy syndrome	0.000249	0.000959	CbGpPWpGaD
Nafarelin—Vomiting—Felbamate—epilepsy syndrome	0.000248	0.000379	CcSEcCtD
Nafarelin—Pruritus—Carbamazepine—epilepsy syndrome	0.000247	0.000377	CcSEcCtD
Nafarelin—Rash—Felbamate—epilepsy syndrome	0.000246	0.000376	CcSEcCtD
Nafarelin—Dermatitis—Felbamate—epilepsy syndrome	0.000246	0.000376	CcSEcCtD
Nafarelin—Vertigo—Gabapentin—epilepsy syndrome	0.000245	0.000374	CcSEcCtD
Nafarelin—Headache—Felbamate—epilepsy syndrome	0.000244	0.000373	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000244	0.000373	CcSEcCtD
Nafarelin—Dizziness—Clonazepam—epilepsy syndrome	0.000243	0.000372	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AVP—epilepsy syndrome	0.000243	0.000939	CbGpPWpGaD
Nafarelin—Nausea—Vigabatrin—epilepsy syndrome	0.000243	0.000372	CcSEcCtD
Nafarelin—Vomiting—Zonisamide—epilepsy syndrome	0.000243	0.000371	CcSEcCtD
Nafarelin—Insomnia—Valproic Acid—epilepsy syndrome	0.000242	0.00037	CcSEcCtD
Nafarelin—Oedema—Pregabalin—epilepsy syndrome	0.000242	0.00037	CcSEcCtD
Nafarelin—Asthenia—Lamotrigine—epilepsy syndrome	0.000242	0.00037	CcSEcCtD
Nafarelin—Dizziness—Phenytoin—epilepsy syndrome	0.000242	0.000369	CcSEcCtD
Nafarelin—Rash—Zonisamide—epilepsy syndrome	0.000241	0.000368	CcSEcCtD
Nafarelin—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000241	0.000368	CcSEcCtD
Nafarelin—Palpitations—Gabapentin—epilepsy syndrome	0.000241	0.000368	CcSEcCtD
Nafarelin—Dermatitis—Zonisamide—epilepsy syndrome	0.000241	0.000368	CcSEcCtD
Nafarelin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00024	0.000367	CcSEcCtD
Nafarelin—Nausea—Diazepam—epilepsy syndrome	0.000239	0.000366	CcSEcCtD
Nafarelin—Headache—Zonisamide—epilepsy syndrome	0.000239	0.000366	CcSEcCtD
Nafarelin—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000239	0.000365	CcSEcCtD
Nafarelin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000239	0.000365	CcSEcCtD
Nafarelin—Pruritus—Lamotrigine—epilepsy syndrome	0.000239	0.000365	CcSEcCtD
Nafarelin—Shock—Pregabalin—epilepsy syndrome	0.000238	0.000364	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000238	0.00092	CbGpPWpGaD
Nafarelin—Convulsion—Gabapentin—epilepsy syndrome	0.000236	0.00036	CcSEcCtD
Nafarelin—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000234	0.000358	CcSEcCtD
Nafarelin—Vomiting—Clonazepam—epilepsy syndrome	0.000234	0.000358	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CHRM2—epilepsy syndrome	0.000234	0.000902	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000234	0.000902	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000234	0.000902	CbGpPWpGaD
Nafarelin—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000233	0.000356	CcSEcCtD
Nafarelin—Alopecia—Topiramate—epilepsy syndrome	0.000232	0.000355	CcSEcCtD
Nafarelin—Vomiting—Phenytoin—epilepsy syndrome	0.000232	0.000355	CcSEcCtD
Nafarelin—Rash—Clonazepam—epilepsy syndrome	0.000232	0.000355	CcSEcCtD
Nafarelin—Dermatitis—Clonazepam—epilepsy syndrome	0.000232	0.000354	CcSEcCtD
Nafarelin—Chest pain—Gabapentin—epilepsy syndrome	0.000232	0.000354	CcSEcCtD
Nafarelin—Arthralgia—Gabapentin—epilepsy syndrome	0.000232	0.000354	CcSEcCtD
Nafarelin—Myalgia—Gabapentin—epilepsy syndrome	0.000232	0.000354	CcSEcCtD
Nafarelin—Nausea—Felbamate—epilepsy syndrome	0.000232	0.000354	CcSEcCtD
Nafarelin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000231	0.000353	CcSEcCtD
Nafarelin—Anorexia—Pregabalin—epilepsy syndrome	0.000231	0.000353	CcSEcCtD
Nafarelin—Dizziness—Carbamazepine—epilepsy syndrome	0.000231	0.000353	CcSEcCtD
Nafarelin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000231	0.000353	CcSEcCtD
Nafarelin—Headache—Clonazepam—epilepsy syndrome	0.000231	0.000352	CcSEcCtD
Nafarelin—Rash—Phenytoin—epilepsy syndrome	0.000231	0.000352	CcSEcCtD
Nafarelin—Mental disorder—Topiramate—epilepsy syndrome	0.00023	0.000352	CcSEcCtD
Nafarelin—Dermatitis—Phenytoin—epilepsy syndrome	0.00023	0.000352	CcSEcCtD
Nafarelin—Rash—Oxcarbazepine—epilepsy syndrome	0.000229	0.00035	CcSEcCtD
Nafarelin—Constipation—Valproic Acid—epilepsy syndrome	0.000229	0.00035	CcSEcCtD
Nafarelin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000229	0.00035	CcSEcCtD
Nafarelin—Headache—Phenytoin—epilepsy syndrome	0.000229	0.00035	CcSEcCtD
Nafarelin—Malnutrition—Topiramate—epilepsy syndrome	0.000229	0.00035	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CDC42—epilepsy syndrome	0.000228	0.000881	CbGpPWpGaD
Nafarelin—Headache—Oxcarbazepine—epilepsy syndrome	0.000228	0.000348	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—GABBR1—epilepsy syndrome	0.000227	0.000877	CbGpPWpGaD
Nafarelin—Nausea—Zonisamide—epilepsy syndrome	0.000227	0.000347	CcSEcCtD
Nafarelin—Tension—Topiramate—epilepsy syndrome	0.000225	0.000343	CcSEcCtD
Nafarelin—Dysgeusia—Topiramate—epilepsy syndrome	0.000224	0.000343	CcSEcCtD
Nafarelin—Dizziness—Lamotrigine—epilepsy syndrome	0.000223	0.000341	CcSEcCtD
Nafarelin—Nervousness—Topiramate—epilepsy syndrome	0.000222	0.00034	CcSEcCtD
Nafarelin—Oedema—Gabapentin—epilepsy syndrome	0.000222	0.00034	CcSEcCtD
Nafarelin—Vomiting—Carbamazepine—epilepsy syndrome	0.000222	0.000339	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—AVP—epilepsy syndrome	0.000221	0.000853	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000221	0.000337	CcSEcCtD
Nafarelin—Rash—Carbamazepine—epilepsy syndrome	0.00022	0.000336	CcSEcCtD
Nafarelin—Dermatitis—Carbamazepine—epilepsy syndrome	0.00022	0.000336	CcSEcCtD
Nafarelin—Insomnia—Pregabalin—epilepsy syndrome	0.000219	0.000335	CcSEcCtD
Nafarelin—Nausea—Clonazepam—epilepsy syndrome	0.000219	0.000334	CcSEcCtD
Nafarelin—Headache—Carbamazepine—epilepsy syndrome	0.000219	0.000334	CcSEcCtD
Nafarelin—Shock—Gabapentin—epilepsy syndrome	0.000219	0.000334	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—HRH3—epilepsy syndrome	0.000218	0.000841	CbGpPWpGaD
Nafarelin—Paraesthesia—Pregabalin—epilepsy syndrome	0.000218	0.000332	CcSEcCtD
Nafarelin—Nausea—Phenytoin—epilepsy syndrome	0.000217	0.000332	CcSEcCtD
Nafarelin—Dyspnoea—Pregabalin—epilepsy syndrome	0.000216	0.00033	CcSEcCtD
Nafarelin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000216	0.00033	CcSEcCtD
Nafarelin—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000215	0.000328	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—OPRM1—epilepsy syndrome	0.000215	0.000828	CbGpPWpGaD
Nafarelin—Vomiting—Lamotrigine—epilepsy syndrome	0.000214	0.000328	CcSEcCtD
Nafarelin—Urticaria—Valproic Acid—epilepsy syndrome	0.000213	0.000325	CcSEcCtD
Nafarelin—Rash—Lamotrigine—epilepsy syndrome	0.000213	0.000325	CcSEcCtD
Nafarelin—Dermatitis—Lamotrigine—epilepsy syndrome	0.000212	0.000325	CcSEcCtD
Nafarelin—Anorexia—Gabapentin—epilepsy syndrome	0.000212	0.000324	CcSEcCtD
Nafarelin—Headache—Lamotrigine—epilepsy syndrome	0.000211	0.000323	CcSEcCtD
Nafarelin—Decreased appetite—Pregabalin—epilepsy syndrome	0.000211	0.000322	CcSEcCtD
Nafarelin—Nausea—Carbamazepine—epilepsy syndrome	0.000207	0.000317	CcSEcCtD
Nafarelin—Constipation—Pregabalin—epilepsy syndrome	0.000207	0.000317	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000207	0.000799	CbGpPWpGaD
Nafarelin—Vertigo—Topiramate—epilepsy syndrome	0.000206	0.000314	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCR3—epilepsy syndrome	0.000203	0.000782	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000203	0.000782	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000202	0.000309	CcSEcCtD
Nafarelin—Palpitations—Topiramate—epilepsy syndrome	0.000202	0.000309	CcSEcCtD
Nafarelin—Insomnia—Gabapentin—epilepsy syndrome	0.000201	0.000307	CcSEcCtD
Nafarelin—Nausea—Lamotrigine—epilepsy syndrome	0.0002	0.000306	CcSEcCtD
Nafarelin—Paraesthesia—Gabapentin—epilepsy syndrome	0.0002	0.000305	CcSEcCtD
Nafarelin—Convulsion—Topiramate—epilepsy syndrome	0.000198	0.000303	CcSEcCtD
Nafarelin—Dyspnoea—Gabapentin—epilepsy syndrome	0.000198	0.000303	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—NPY—epilepsy syndrome	0.000197	0.000762	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000197	0.000762	CbGpPWpGaD
Nafarelin—Myalgia—Topiramate—epilepsy syndrome	0.000195	0.000298	CcSEcCtD
Nafarelin—Arthralgia—Topiramate—epilepsy syndrome	0.000195	0.000298	CcSEcCtD
Nafarelin—Chest pain—Topiramate—epilepsy syndrome	0.000195	0.000298	CcSEcCtD
Nafarelin—Decreased appetite—Gabapentin—epilepsy syndrome	0.000193	0.000295	CcSEcCtD
Nafarelin—Urticaria—Pregabalin—epilepsy syndrome	0.000192	0.000294	CcSEcCtD
Nafarelin—Asthenia—Valproic Acid—epilepsy syndrome	0.000192	0.000294	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AGT—epilepsy syndrome	0.000192	0.000742	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HSPB1—epilepsy syndrome	0.00019	0.000735	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—OXT—epilepsy syndrome	0.00019	0.000735	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL2—epilepsy syndrome	0.00019	0.000735	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CRH—epilepsy syndrome	0.00019	0.000735	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL3—epilepsy syndrome	0.00019	0.000735	CbGpPWpGaD
Nafarelin—Constipation—Gabapentin—epilepsy syndrome	0.00019	0.00029	CcSEcCtD
Nafarelin—Pruritus—Valproic Acid—epilepsy syndrome	0.00019	0.00029	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCR5—epilepsy syndrome	0.000188	0.000725	CbGpPWpGaD
Nafarelin—Oedema—Topiramate—epilepsy syndrome	0.000187	0.000286	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000184	0.00071	CbGpPWpGaD
Nafarelin—Shock—Topiramate—epilepsy syndrome	0.000184	0.000281	CcSEcCtD
Nafarelin—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000183	0.00028	CcSEcCtD
Nafarelin—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000181	0.000276	CcSEcCtD
Nafarelin—Anorexia—Topiramate—epilepsy syndrome	0.000178	0.000272	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000178	0.000685	CbGpPWpGaD
Nafarelin—Dizziness—Valproic Acid—epilepsy syndrome	0.000177	0.000271	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PTK2B—epilepsy syndrome	0.000177	0.000684	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TSC1—epilepsy syndrome	0.000177	0.000684	CbGpPWpGaD
Nafarelin—Urticaria—Gabapentin—epilepsy syndrome	0.000177	0.00027	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—AGT—epilepsy syndrome	0.000174	0.000674	CbGpPWpGaD
Nafarelin—Asthenia—Pregabalin—epilepsy syndrome	0.000174	0.000266	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—SST—epilepsy syndrome	0.000172	0.000665	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NTRK2—epilepsy syndrome	0.000172	0.000665	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR2—epilepsy syndrome	0.000172	0.000665	CbGpPWpGaD
Nafarelin—Pruritus—Pregabalin—epilepsy syndrome	0.000171	0.000262	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—DUSP6—epilepsy syndrome	0.000171	0.000659	CbGpPWpGaD
Nafarelin—Vomiting—Valproic Acid—epilepsy syndrome	0.00017	0.00026	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.00017	0.00026	CcSEcCtD
Nafarelin—Insomnia—Topiramate—epilepsy syndrome	0.000169	0.000258	CcSEcCtD
Nafarelin—Rash—Valproic Acid—epilepsy syndrome	0.000169	0.000258	CcSEcCtD
Nafarelin—Dermatitis—Valproic Acid—epilepsy syndrome	0.000169	0.000258	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000169	0.000651	CbGpPWpGaD
Nafarelin—Headache—Valproic Acid—epilepsy syndrome	0.000168	0.000257	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PLAT—epilepsy syndrome	0.000168	0.000648	CbGpPWpGaD
Nafarelin—Paraesthesia—Topiramate—epilepsy syndrome	0.000168	0.000256	CcSEcCtD
Nafarelin—Dyspnoea—Topiramate—epilepsy syndrome	0.000167	0.000255	CcSEcCtD
Nafarelin—Diarrhoea—Pregabalin—epilepsy syndrome	0.000166	0.000253	CcSEcCtD
Nafarelin—Decreased appetite—Topiramate—epilepsy syndrome	0.000162	0.000248	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000162	0.000625	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL12—epilepsy syndrome	0.000162	0.000625	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—POMC—epilepsy syndrome	0.000162	0.000624	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000161	0.000622	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000161	0.00062	CbGpPWpGaD
Nafarelin—Dizziness—Pregabalin—epilepsy syndrome	0.00016	0.000245	CcSEcCtD
Nafarelin—Constipation—Topiramate—epilepsy syndrome	0.00016	0.000244	CcSEcCtD
Nafarelin—Asthenia—Gabapentin—epilepsy syndrome	0.000159	0.000244	CcSEcCtD
Nafarelin—Nausea—Valproic Acid—epilepsy syndrome	0.000159	0.000243	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—JUNB—epilepsy syndrome	0.000159	0.000614	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CNR1—epilepsy syndrome	0.000159	0.000614	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PLCB1—epilepsy syndrome	0.000158	0.000612	CbGpPWpGaD
Nafarelin—Pruritus—Gabapentin—epilepsy syndrome	0.000157	0.00024	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—HTR7—epilepsy syndrome	0.000155	0.000599	CbGpPWpGaD
Nafarelin—Vomiting—Pregabalin—epilepsy syndrome	0.000154	0.000235	CcSEcCtD
Nafarelin—Rash—Pregabalin—epilepsy syndrome	0.000153	0.000233	CcSEcCtD
Nafarelin—Dermatitis—Pregabalin—epilepsy syndrome	0.000153	0.000233	CcSEcCtD
Nafarelin—Diarrhoea—Gabapentin—epilepsy syndrome	0.000152	0.000232	CcSEcCtD
Nafarelin—Headache—Pregabalin—epilepsy syndrome	0.000152	0.000232	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—HBEGF—epilepsy syndrome	0.000151	0.000581	CbGpPWpGaD
Nafarelin—Urticaria—Topiramate—epilepsy syndrome	0.000148	0.000227	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—AKT3—epilepsy syndrome	0.000148	0.000571	CbGpPWpGaD
Nafarelin—Dizziness—Gabapentin—epilepsy syndrome	0.000147	0.000225	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—POMC—epilepsy syndrome	0.000147	0.000567	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADAM10—epilepsy syndrome	0.000144	0.000557	CbGpPWpGaD
Nafarelin—Nausea—Pregabalin—epilepsy syndrome	0.000144	0.00022	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL2—epilepsy syndrome	0.000144	0.000555	CbGpPWpGaD
Nafarelin—Vomiting—Gabapentin—epilepsy syndrome	0.000141	0.000216	CcSEcCtD
Nafarelin—Rash—Gabapentin—epilepsy syndrome	0.00014	0.000214	CcSEcCtD
Nafarelin—Dermatitis—Gabapentin—epilepsy syndrome	0.00014	0.000214	CcSEcCtD
Nafarelin—Headache—Gabapentin—epilepsy syndrome	0.000139	0.000213	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—S100B—epilepsy syndrome	0.000137	0.000527	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SOCS3—epilepsy syndrome	0.000135	0.000522	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CDC42—epilepsy syndrome	0.000135	0.000521	CbGpPWpGaD
Nafarelin—Asthenia—Topiramate—epilepsy syndrome	0.000134	0.000205	CcSEcCtD
Nafarelin—Pruritus—Topiramate—epilepsy syndrome	0.000132	0.000202	CcSEcCtD
Nafarelin—Nausea—Gabapentin—epilepsy syndrome	0.000132	0.000202	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—AVP—epilepsy syndrome	0.000131	0.000504	CbGpPWpGaD
Nafarelin—Diarrhoea—Topiramate—epilepsy syndrome	0.000128	0.000195	CcSEcCtD
Nafarelin—Dizziness—Topiramate—epilepsy syndrome	0.000124	0.000189	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—HES1—epilepsy syndrome	0.000123	0.000477	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—FYN—epilepsy syndrome	0.00012	0.000463	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—H2AFX—epilepsy syndrome	0.00012	0.000462	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MEF2C—epilepsy syndrome	0.000119	0.000461	CbGpPWpGaD
Nafarelin—Vomiting—Topiramate—epilepsy syndrome	0.000119	0.000182	CcSEcCtD
Nafarelin—Rash—Topiramate—epilepsy syndrome	0.000118	0.00018	CcSEcCtD
Nafarelin—Dermatitis—Topiramate—epilepsy syndrome	0.000118	0.00018	CcSEcCtD
Nafarelin—Headache—Topiramate—epilepsy syndrome	0.000117	0.000179	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000115	0.000446	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NGF—epilepsy syndrome	0.000114	0.000441	CbGpPWpGaD
Nafarelin—Nausea—Topiramate—epilepsy syndrome	0.000111	0.00017	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCR5—epilepsy syndrome	0.000111	0.000429	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR2A—epilepsy syndrome	0.000109	0.000419	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TSC2—epilepsy syndrome	0.000103	0.000398	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AGT—epilepsy syndrome	0.000103	0.000398	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOE—epilepsy syndrome	0.000101	0.00039	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—KDR—epilepsy syndrome	9.89e-05	0.000382	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCB—epilepsy syndrome	9.52e-05	0.000368	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6ST—epilepsy syndrome	9.49e-05	0.000366	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—POMC—epilepsy syndrome	8.68e-05	0.000335	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL2—epilepsy syndrome	8.49e-05	0.000328	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—FGF2—epilepsy syndrome	7.67e-05	0.000296	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RELA—epilepsy syndrome	7.12e-05	0.000275	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MTOR—epilepsy syndrome	6.98e-05	0.00027	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AKT1—epilepsy syndrome	6.48e-05	0.00025	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CASP3—epilepsy syndrome	6.42e-05	0.000248	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—JUN—epilepsy syndrome	6.24e-05	0.000241	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MMP9—epilepsy syndrome	6.07e-05	0.000234	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AKT1—epilepsy syndrome	5.89e-05	0.000227	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SRC—epilepsy syndrome	5.6e-05	0.000216	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VEGFA—epilepsy syndrome	5.45e-05	0.00021	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKT1—epilepsy syndrome	3.48e-05	0.000134	CbGpPWpGaD
